Cephalexin Articles
Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid
20 October 2009
Targanta presents more oritavancin data at ICAAC
10 November 2008
Vietnam to resist drug price hike calls
2 June 2008
Indian Pharma cuts 886 drug prices
13 November 2006
Advancis buys Lilly's Keflex brand for $11M
5 July 2004
Indian firms win US approvals, other news
6 October 2003
New pivotal data for InterMune's oritavancin
22 September 2003
Australia-US trade deal: Rx price warning
11 August 2003
Glaxo & Ranbaxy to expand abroad?
12 May 1999
Ranbaxy drug trial
17 March 1999
Max-GB Establishes Penicillin Plant
1 October 1998
Lupin Set To Make Acquisition In USA
3 June 1998
Indian Drug Prices Discussed In Parliament
12 August 1997
US Quarterly Results Show Improvements
4 November 1996
Eli Lilly Investing In Brazil
23 September 1996
Israel's Teva Bidding For World Generics Leadership
12 February 1996
Warner-Lambert's cefdinir: new findings
2 October 1995
Eli Lilly Opens Manufacturing Plant
6 March 1995
$25 Bill Latin American Pharma Market In 2000
9 January 1995
LILLY RECALLS ANTIBIOTICS
11 April 1994
NORTON ADDS NEW PRODUCTS IN UK
21 March 1994
BARR LABS REINTRODUCES THREE PRODUCTS
27 September 1993
BARR LABS HAS 24 PRODUCTS SUSPENDED
15 February 1993
BIOCRAFT BOOSTED BY APPROVALS
13 April 1992
BIOCRAFT SETS SIGHTS ON GENERIC CECLOR
17 February 1992
Showing 1-28 of 28 articles
- 1
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
